by admin | Nov 25, 2022 | News & Opinions
By Terry Gross – NPR news Dr. Siddhartha Mukherjee still remembers the first cell he cultured: It was an immune cell from a mouse, and he had grown it in a petri dish. As he examined it through a microscope, the cell moved, and Mukherjee was fascinated....
by admin | Nov 21, 2022 | News & Opinions
The new model cells aid in the study of early embryonic development. by KU Leuven – SciTechDaily Professor Vincent Pasque and his colleagues at KU Leuven have used stem cells to create a new kind of human cell in the lab. The new cells closely mirror their...
by admin | Nov 20, 2022 | News & Opinions
Markers of nerve damage fell significantly in most patients after transplant by Marisa Wexler – Multiple Sclerosis News Today Autologous hematopoietic stem cell transplant (aHSCT) reduces markers of nerve fiber and myelin damage in people with...
by admin | Nov 18, 2022 | News & Opinions
By Greg Slabodkin, ScienceBoard Editor in Chief The U.S. Food and Drug Administration (FDA) has elevated and reorganized its Office of Tissues and Advanced Therapies (OTAT) to a “Super Office” within the Center of Biologics Research and Evaluation (CBER) to meet its...
by admin | Nov 17, 2022 | News & Opinions
An experiment tests whether the gene-editing technology can stop the virus from replicating, which would ultimately wipe out the infection. By Wired.com In July, an HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to...
